Research ethics. Beyond access vs. protection in trials of innovative therapies
- PMID: 20466907
- PMCID: PMC4516403
- DOI: 10.1126/science.1189369
Research ethics. Beyond access vs. protection in trials of innovative therapies
Abstract
Review of first-in-human trials should aim to safeguard the integrity of the scientific enterprise through a focus on pre-clinical and clinical study quality.
References
-
- Couzin J, Vogel G. Science. 2004 Apr 9;304:192. - PubMed
-
- Alper J. Nat Biotechnol. 2009 Mar;27:213. - PubMed
-
- California Institute for Regenerative Medicine. 2009 http://www.cirm.ca.gov/PressRelease_102809.
-
- Lo B, et al. Stem Cells. 2005 Nov-Dec;23:1454.
-
- Lancet. 2005 Jun 11–17;365:1984.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
